Inhibition of and IL-6 in Osteoblast-Like Cell by Isoflavones Extracted from Sophorae fructus |
Joo, Seong-Soo
(Department of Immunology, College of Pharmacy, Chung-Ang University)
Kang, Hee-Cheol (Department of Immunology, College of Pharmacy, Chung-Ang University) Choi, Min-Won (Department of Immunology, College of Pharmacy, Chung-Ang University) Choi, Young-Wook (Department of Immunology, College of Pharmacy, Chung-Ang University) Lee, Do-ik (Department of Immunology, College of Pharmacy, Chung-Ang University) |
1 | Duncan, A. M., Phipps, W. R., and Kurzer, M. S., Phytooestrogen. Best Practice & Research Clinical Endocrinology and Metabolism, 17, 253-271 (2003) DOI ScienceOn |
2 | Felix, R., Cecchini, M. G., Hofstetter, W., Elford, P. R., Stutzer, A., and Fleishi, H., Impatient of macrophage colony-stimulating factor production and lack of resident bone marrow macrophage in the osteoporotic op/op mouse. J. Bone Miner. Res., 5, 781-789 (1990) DOI PUBMED ScienceOn |
3 | Greenfield, E. M., Bi, Y., and Miyauchi, A., Regulation of osteoclast activity. Life Sicence, 65, 1087-1102 (1999) DOI ScienceOn |
4 | Joo, S. S., Chang, J. K., Park, J. H., Kang, H. C., and Lee, D. I., Immuno activation of lectin-conjugated praecoxin A on IL-6, IL-12 expression. Arch. Pharm. Res., 25, 954-963 (2002) DOI ScienceOn |
5 | Riggs, B. L., Khosia, S., and Melton, L. J., A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J. Bone Miner. Res., 13, 763-773 (1998) DOI ScienceOn |
6 | Stanley, E. R. and Heard, P. M., Factors regulating macrophage production and growth: Purification and some properties of the colony-stimulating factor from medium conditioned by mouse L cells. J. Biol. Chem., 252, 4305-4321 (1977) PUBMED |
7 | vant Hof, R. J. and Ralston, S. H., Nitric oxide and bone. Immunology, 103, 255-261 (2001) DOI ScienceOn |
8 | Yamaguchi, M. and Gao, Y. H., Inhibitory effect of genistein on bone resorption in tissue culture. Biochem. Phamacol., 55, 71-76 (1998) DOI ScienceOn |
9 | Ragab, A. A., Nalepka, J. L., Bi, Y., and Greenfield, E. M., Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells. Am. J. Physiol. Cell Physiol., 283, C679-C687 (2002) DOI PUBMED ScienceOn |
10 | Fujikawa, Y., Sabokbar, A., Neale, D., Itonaga, I., Torisu, T., and Athanasou, A., The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells. Bone, 28, 261-267 (2001) DOI ScienceOn |
11 | Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Yano, K., Morinaga, T., and Higashio, K., RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem. Biophys. Res. Commun., 253, 395-400 (1998) DOI ScienceOn |
12 | Setchell, K. D., Abstract presented at: Second international symposium on the role of soy in preventing and treating chronic disease. Brussel Belgium , (1996) |
13 | Wimalawansa, S. J., De Marco, G., Gangula, P., and Yallampalli, Nitric oxide donor alleviates ovariectomy-induced bone loss. Bone, 18, 301-304 (1996) DOI ScienceOn |
14 | Amonkar, M. M. and Mody, R., Developing profiles of post-menopausal women being prescribed oestrogen therapy to prevent osteoporosis. J. Commun. Health, 27, 335-350 (2002) DOI ScienceOn |
15 | Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Akatsu, T., Koishihara, Y., Ohsugi, Y., Kumaki, K., Taga, T., Kishmoto, T., and Suda, T., Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc. Natl. Acad. Sci. USA, 90, 11924-11928 (1993) DOI ScienceOn |
16 | Eastel, R., Treatment of postmenopausal osteoporosis. N. Engl. J. Med., 338, 736-746 (1998) DOI PUBMED ScienceOn |
17 | Swolin-Eide, D. and Ohlsson, C., Effects of cortisol on the expression of interleukin-6 and interleukin-1 in human osteoblast like cells. J. Endocrinology, 156, 107-114 (1998) DOI ScienceOn |
18 | Raisz, L. G., The osteoporosis revolution. Ann. Intern. Med., 126, 458-462 (1997) DOI PUBMED ScienceOn |
19 | Klein-Nulend, J., Helfrich, M. H., Sterck, J. G., MacPherson, H., Joldersma, M., Ralson, S. H., Semeins, C. M., and Burger, E. H, Nitric oxide response to shear stress by human bone cell culture is endothelial nitric oxide synthase dependant. Biochem. Biophys. Res. Commun., 250, 108-114 (1998) DOI ScienceOn |
20 | Armour, K. E. and Ralston, S. H., Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells. Endocrinology, 139, 799-802 (1998) DOI ScienceOn |
21 | Udagawa, N., Takahashi, N., Matsuzaki, K., Jimi, E., Tsurukai, T., Itoh, K., Nakagawa, H., Yasuda, H., Goto, M., Tsuda, E., Higashio, K., Martin, T. J., and Suda, T., Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand. Bone, 5, 517-523 (1999) |
22 | Tai, H., Miyaura, C., Pilbeam, C. C., Tamura, T., Ohsugi, Y., Koishihara, Y., Kubodera, N., Kawaguchi, H., Raisz, L. G., and Suda, T., Transcriptional induction of cyclooxygenase-2 in osteoblast is involved in interleukin-6-induced osteocalst formation. Endocrinology, 138, 2372-2397 (1997) DOI ScienceOn |
23 | Messina, M. and Messina, V., Soyfood, soybean isoflavone, and bone health: a brief overview. J. Ren. Nutri., 10, 63-68 (2000) DOI ScienceOn |
24 | Pacifici, R., Cytokines, estrogen and postmenopausal osteoporosis- the second decade. Endocrinology, 139, 2659-2661 (1998) DOI PUBMED ScienceOn |
25 | MacIntyre, I., Zaidi, M., Towhidul Alam, A. S. M., Datta, H. K., Moonga, B. S., Lidbury, P. S., Hecker, M., and Vane, J. R., Osteoclastic inhibition: An action of nitric oxide not mediated by cyclic GMP. Proc. Natl. Acad. Sci. USA, 88, 2936-2940 (1991) DOI ScienceOn |
26 | Adlercreutz, H., Phyto-oestrogens and cancer. Lancet Oncology, 3, 364-373 (2002) DOI PUBMED ScienceOn |
27 | Lader, C. S. and Flanagan, A. M., Prostaglandin , interleukin , and tumor necrosis factor- increase human osteoclast formation and bone resorption in vitro. Endocrinology, 139, 3157-3164 (1998) DOI PUBMED ScienceOn |